1. Home
  2. ZURA vs FSTR Comparison

ZURA vs FSTR Comparison

Compare ZURA & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • FSTR
  • Stock Information
  • Founded
  • ZURA 2022
  • FSTR 1902
  • Country
  • ZURA United States
  • FSTR United States
  • Employees
  • ZURA N/A
  • FSTR N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • FSTR Metal Fabrications
  • Sector
  • ZURA Health Care
  • FSTR Industrials
  • Exchange
  • ZURA Nasdaq
  • FSTR Nasdaq
  • Market Cap
  • ZURA 69.9M
  • FSTR 205.4M
  • IPO Year
  • ZURA N/A
  • FSTR N/A
  • Fundamental
  • Price
  • ZURA $1.18
  • FSTR $24.29
  • Analyst Decision
  • ZURA Buy
  • FSTR Hold
  • Analyst Count
  • ZURA 7
  • FSTR 1
  • Target Price
  • ZURA $14.33
  • FSTR $25.00
  • AVG Volume (30 Days)
  • ZURA 709.5K
  • FSTR 33.4K
  • Earning Date
  • ZURA 08-08-2025
  • FSTR 08-05-2025
  • Dividend Yield
  • ZURA N/A
  • FSTR N/A
  • EPS Growth
  • ZURA N/A
  • FSTR 361.43
  • EPS
  • ZURA N/A
  • FSTR 3.34
  • Revenue
  • ZURA N/A
  • FSTR $504,237,000.00
  • Revenue This Year
  • ZURA N/A
  • FSTR $3.80
  • Revenue Next Year
  • ZURA N/A
  • FSTR $3.63
  • P/E Ratio
  • ZURA N/A
  • FSTR $7.28
  • Revenue Growth
  • ZURA N/A
  • FSTR N/A
  • 52 Week Low
  • ZURA $0.97
  • FSTR $14.23
  • 52 Week High
  • ZURA $5.07
  • FSTR $29.78
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 48.73
  • FSTR 81.66
  • Support Level
  • ZURA $1.00
  • FSTR $21.76
  • Resistance Level
  • ZURA $1.22
  • FSTR $22.51
  • Average True Range (ATR)
  • ZURA 0.08
  • FSTR 0.66
  • MACD
  • ZURA -0.00
  • FSTR 0.39
  • Stochastic Oscillator
  • ZURA 52.00
  • FSTR 100.00

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About FSTR L.B. Foster Company

L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

Share on Social Networks: